OA10125A - Lysozyme dimer and compositions containing the same - Google Patents

Lysozyme dimer and compositions containing the same Download PDF

Info

Publication number
OA10125A
OA10125A OA60604A OA60604A OA10125A OA 10125 A OA10125 A OA 10125A OA 60604 A OA60604 A OA 60604A OA 60604 A OA60604 A OA 60604A OA 10125 A OA10125 A OA 10125A
Authority
OA
OAPI
Prior art keywords
lysozyme
dimer
manufac
ture
dimerised
Prior art date
Application number
OA60604A
Other languages
English (en)
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of OA10125A publication Critical patent/OA10125A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
OA60604A 1992-07-13 1995-01-13 Lysozyme dimer and compositions containing the same OA10125A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL92295273A PL173978B1 (pl) 1992-07-13 1992-07-13 Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej

Publications (1)

Publication Number Publication Date
OA10125A true OA10125A (en) 1996-12-18

Family

ID=20058087

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60604A OA10125A (en) 1992-07-13 1995-01-13 Lysozyme dimer and compositions containing the same

Country Status (31)

Country Link
US (1) US6132715A (bg)
EP (1) EP0651654B1 (bg)
JP (1) JPH07508744A (bg)
KR (1) KR100289841B1 (bg)
CN (1) CN1057937C (bg)
AT (1) ATE252392T1 (bg)
AU (1) AU677786B2 (bg)
BG (1) BG63331B1 (bg)
BR (1) BR9306722A (bg)
CA (1) CA2140140A1 (bg)
CZ (1) CZ286725B6 (bg)
DE (2) DE69333258T2 (bg)
DK (1) DK0651654T3 (bg)
ES (1) ES2074037T3 (bg)
FI (1) FI950144A (bg)
GE (1) GEP20012466B (bg)
GR (1) GR950300039T1 (bg)
HU (1) HU218151B (bg)
MX (1) MX9304197A (bg)
NZ (2) NZ254135A (bg)
OA (1) OA10125A (bg)
PL (1) PL173978B1 (bg)
PT (1) PT651654E (bg)
RO (1) RO112580B1 (bg)
RU (1) RU2145875C1 (bg)
SG (1) SG52727A1 (bg)
SK (1) SK282377B6 (bg)
TW (1) TW259710B (bg)
UA (1) UA49789C2 (bg)
WO (1) WO1994001127A1 (bg)
ZA (1) ZA935046B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
AU5884096A (en) * 1995-05-30 1996-12-18 Lectin Biopharma, Inc. Method of using lectins for agglutination and collection of menstrual flow
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
ITMI981148A1 (it) 1998-05-22 1999-11-22 Therapicon Srl Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
EP1174147A1 (en) * 2000-06-27 2002-01-23 Nika Health Products Limited Reversal of antibiotic resistance with lysozyme dimer
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
RU2472467C2 (ru) * 2011-04-13 2013-01-20 Государственное научное учреждение Краснодарский научно-исследовательский ветеринарный институт (ГНУ КНИВИ) Способ профилактики и лечения гастроэнтеритов, обусловленных бактериозами, у телят
RU2546911C2 (ru) * 2013-04-11 2015-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Донской государственный аграрный университет" Способ хранения свинины в охлажденном состоянии
CN105106626A (zh) * 2015-09-30 2015-12-02 成都倍加特生物科技有限公司 一种治疗月经期感染的汤剂药物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4020M (bg) * 1965-01-29 1966-03-21
FR2215201A1 (en) * 1973-01-24 1974-08-23 Theranol Lab Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent
JPS5533409A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Carcinostatic agent
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4457919A (en) * 1980-03-14 1984-07-03 Newport Pharmaceutical International, Inc. Method of imparting immunomodulating, antiviral or antitumor activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
DE68927733T2 (de) * 1988-05-31 1997-06-12 Napp Systems Inc., San Marcos, Calif. Vorrichtung und verfahren zur behandlung von druckplatten
AU6355190A (en) * 1989-06-13 1991-01-17 Smithkline Beecham Corporation Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
WO1991010731A1 (en) * 1990-01-08 1991-07-25 Nika Health Products Ltd. Method of preparing lysozyme dimers
US5314816A (en) * 1990-01-08 1994-05-24 Nika Health Products Ltd. Method of preparing lysozyme dimers
DK0542795T5 (da) * 1990-08-03 1998-09-07 Smithkline Beecham Corp TNF-inhibitorer

Also Published As

Publication number Publication date
BG63331B1 (bg) 2001-10-31
EP0651654B1 (en) 2003-10-22
MX9304197A (es) 1994-02-28
AU677786B2 (en) 1997-05-08
HUT70973A (en) 1995-11-28
FI950144A0 (fi) 1995-01-12
HU9500098D0 (en) 1995-03-28
ES2074037T3 (es) 2004-07-01
KR100289841B1 (ko) 2001-05-15
BR9306722A (pt) 1998-12-08
SK4095A3 (en) 1995-09-13
PL295273A1 (en) 1994-01-24
SG52727A1 (en) 1998-09-28
WO1994001127A1 (en) 1994-01-20
GEP20012466B (en) 2001-06-25
CZ286725B6 (en) 2000-06-14
SK282377B6 (sk) 2002-01-07
DE69333258T2 (de) 2004-08-26
CA2140140A1 (en) 1994-01-20
TW259710B (bg) 1995-10-11
DE69333258D1 (de) 2003-11-27
RU2145875C1 (ru) 2000-02-27
RO112580B1 (ro) 1997-11-28
NZ299377A (en) 2001-02-23
NZ254135A (en) 1996-11-26
PT651654E (pt) 2004-03-31
US6132715A (en) 2000-10-17
EP0651654A1 (en) 1995-05-10
AU4568693A (en) 1994-01-31
JPH07508744A (ja) 1995-09-28
ZA935046B (en) 1994-02-07
BG99287A (bg) 1995-08-28
PL173978B1 (pl) 1998-05-29
UA49789C2 (uk) 2002-10-15
KR950702432A (ko) 1995-07-29
DE651654T1 (de) 1996-01-04
HU218151B (hu) 2000-06-28
FI950144A (fi) 1995-01-12
GR950300039T1 (en) 1995-07-31
ATE252392T1 (de) 2003-11-15
CN1057937C (zh) 2000-11-01
CZ8595A3 (en) 1995-09-13
ES2074037T1 (es) 1995-09-01
DK0651654T3 (da) 2004-02-23
CN1087278A (zh) 1994-06-01

Similar Documents

Publication Publication Date Title
CA1335425C (en) Antiviral or antibacterial compound and method of use
Liu et al. Staphylococcal peptidoglycans induce arthritis
Miyamoto et al. Antitumor activity of oenothein B, a unique macrocyclic ellagitannin
OA10125A (en) Lysozyme dimer and compositions containing the same
EP0568200A2 (en) Pharmaceutical and foodstuff compositions containing transferrius and antibacteral agents for potentiating host defense activity and the treatment of infections
Hirakata et al. Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice
KR0145553B1 (ko) 클로스트리듐 디피실레 하리증 및 위막성 대장염의 예방 및 치료용 의약조성물
SHERWOOD et al. Glucan phosphate potentiates endotoxin-induced interferon-γ expression in immunocompetent mice, but attenuates induction of endotoxin tolerance
US5336488A (en) Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
Schade et al. Endotoxin-tolerant mice produce an inhibitor of tumor necrosis factor synthesis
EP0405315A2 (en) Use of a phagocyte-activating agent : LPS or IL-2 for the manufacture of a medicament for treating staphylococcus aureus infection in cows
Guruvayoorappan et al. Rutin inhibits nitric oxide and tumor necrosis factor-α production in lipopolysaccharide and concanavalin-A stimulated macrophages
EP0548558A2 (en) Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases
PL176407B1 (pl) Kompozycja farmaceutyczna zawierająca dimer lizozymu
KR19990034654A (ko) 프로폴리스의 추출방법과 면역증강제로서의 용도
Bryer The chemotherapy of bacterial infections refractory to the common antibiotics
Assiri et al. Assessment of Cytokine Release in Septic Shock Induced by Some Antibiotics
KR19990034653A (ko) 프로폴리스가 함유된 가축사료 및 이를 사용하여 생산된 축산물
Mago et al. Efficacy of an immunomodulating drug in immunodeficient and immunocompetent mice